19 results
424B5
SEEL
Seelos Therapeutics Inc
20 May 24
Prospectus supplement for primary offering
4:16pm
, supply chain and operations;
risks and uncertainties associated with our actual and proposed research and development activities, including our
424B3
SEEL
Seelos Therapeutics Inc
15 Mar 24
Prospectus supplement
4:15pm
, preclinical studies, supply chain and operations;
risks and uncertainties associated with our actual and proposed research and development activities
424B5
SEEL
Seelos Therapeutics Inc
30 Jan 24
Prospectus supplement for primary offering
6:05am
, including disruptions to our clinical trials, preclinical studies, supply chain and operations;
risks and uncertainties associated with our actual
424B5
i37fw8u2 q6ri0
30 Nov 23
Prospectus supplement for primary offering
4:58pm
424B5
t60si71q
28 Nov 23
Prospectus supplement for primary offering
4:06pm
424B5
kl34mhl1ge5rp8i
25 Sep 23
Prospectus supplement for primary offering
6:02am
424B5
amcmw1jh
12 May 22
Prospectus supplement for primary offering
8:30am
424B5
axmk9oc46fv0djg
21 May 21
Prospectus supplement for primary offering
12:00am
424B5
0ur76c
19 May 21
Prospectus supplement for primary offering
4:08pm
424B5
5xly2rrzhhd5 sqir9
26 Jan 21
Prospectus supplement for primary offering
5:11pm
424B5
osrclf4y2o21
25 Jan 21
Prospectus supplement for primary offering
4:16pm
424B3
nehiwpdg
4 Dec 20
Prospectus supplement
4:48pm
424B5
2hsvcf63yc3nxw4
8 Sep 20
Prospectus supplement for primary offering
4:43pm
8-K
EX-10.1
y8gzo 22r
20 Oct 14
Apricus Expands Development Pipeline
12:00am
- Prev
- 1
- Next